Vivaldis Pimoben Solo 1.25mg is a prescription-only veterinary cardiovascular medication formulated for the management and long-term treatment of congestive heart failure (CHF) in small and toy breed dogs. Unlike combined heart treatments, the "Solo" formulation focuses exclusively on providing a pure dose of Pimobendan (1.25mg) without the addition of ACE inhibitors like benazepril, allowing for precise, customized adjustments based on a canine patient’s exact cardiac needs.

Operating as a powerful "inodilator," Pimobendan delivers a crucial dual action: it acts as a calcium sensitizer to directly improve the contractility and efficiency of the heart muscle while simultaneously inhibiting phosphodiesterase III (PDE3) to dilate peripheral blood vessels. This mechanisms effectively alleviates structural workload on weak heart chambers, maximizes cardiac output, and reduces systemic vascular pressure. It is heavily utilized for small dogs suffering from myxomatous mitral valve disease (MMVD), dilated cardiomyopathy (DCM), or early-stage preclinical heart conditions. Administered orally on an empty stomach twice daily, these palatable tablets safely reduce debilitating symptoms like coughing, breathlessness, and chronic lethargy.